- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TriSalus Life Sciences Inc (TLSI)
TriSalus Life Sciences Inc stock price live, this page displays NASDAQ TLSI stock exchange data. View the TLSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TriSalus Life Sciences Inc real time stock price chart below.
What Is the TriSalus Life Sciences Inc Stock Price Today?
The TriSalus Life Sciences Inc stock price today is 5.780.
What Is the Stock Symbol for TriSalus Life Sciences Inc?
The stock symbol for TriSalus Life Sciences Inc is "TLSI."
What Stock Exchange Does TriSalus Life Sciences Inc Trade On?
TriSalus Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is TriSalus Life Sciences Inc a Good Stock to Buy?
Determining whether TriSalus Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLSI quote. (ISIN: US89680M1018)
What Is the TriSalus Life Sciences Inc Stock Price Today?
The TriSalus Life Sciences Inc stock price today is 5.780.
What Is the Stock Symbol for TriSalus Life Sciences Inc?
The stock symbol for TriSalus Life Sciences Inc is "TLSI."
What Stock Exchange Does TriSalus Life Sciences Inc Trade On?
TriSalus Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is TriSalus Life Sciences Inc a Good Stock to Buy?
Determining whether TriSalus Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TLSI quote. (ISIN: US89680M1018)
NASDAQ
Currency in USD
5.780
-0.330(-5.40%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.700
6.130
52 wk Range
3.420
7.950
TLSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.7006.130
52 wk Range
3.4207.950
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TLSI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.500
Upside
+98.96%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
TriSalus Life Sciences Inc Company Profile
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers. It offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. The company was founded in 2009 and is headquartered in Westminster, Colorado.
TriSalus Life Sciences Inc Earnings Call Summary for Q3/2025
- TriSalus Life Sciences reported Q3 2025 revenue of $11.6 million, up 57% YoY, despite stock closing slightly lower at $4.42. Gross margin declined to 84% from 86% with $9M operating loss.
- The company maintained its 50% revenue growth guidance and aims to achieve EBITDA positivity by H1 2026, while reducing cash used in operations to $3.7M from $11.2M in Q3 2024.
- TriNav Flex and TriNav XP product launches were highlighted as key drivers of growth, with CEO Mary Szela emphasizing the transformative potential of pressure-enabled drug delivery technology.
- Management expressed cautious optimism about genicular artery embolization opportunities while acknowledging ongoing challenges from operating losses and competitive pressures.
Last Updated: 11/14/2025, 06:44 AM
Read Full TranscriptCompare TLSI to Peers and Sector
Metrics to compare | TLSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTLSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | −2.2x | −0.6x | |
PEG Ratio | −0.38 | −0.09 | 0.00 | |
Price/Book | −10.8x | 3.2x | 2.6x | |
Price / LTM Sales | 7.2x | 111.9x | 3.3x | |
Upside (Analyst Target) | 80.0% | 213.6% | 42.7% | |
Fair Value Upside | Unlock | 8.9% | 4.7% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.500
(+98.96% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.96 / --
Revenue / Forecast
11.57M / 12.56M
People Also Watch
FAQ
What Is the TriSalus Life Sciences (TLSI) Stock Price Today?
The TriSalus Life Sciences stock price today is 5.780
What Stock Exchange Does TriSalus Life Sciences Trade On?
TriSalus Life Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for TriSalus Life Sciences?
The stock symbol for TriSalus Life Sciences is "TLSI."
What Is the TriSalus Life Sciences Market Cap?
As of today, TriSalus Life Sciences market cap is 289.79M.
What Is TriSalus Life Sciences's Earnings Per Share (TTM)?
The TriSalus Life Sciences EPS (TTM) is -2.14.
From a Technical Analysis Perspective, Is TLSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has TriSalus Life Sciences Stock Split?
TriSalus Life Sciences has split 0 times.
How Many Employees Does TriSalus Life Sciences Have?
TriSalus Life Sciences has 110 employees.
What is the current trading status of TriSalus Life Sciences (TLSI)?
As of Jan 06, 2026, TriSalus Life Sciences (TLSI) is trading at a price of 5.780, with a previous close of 6.110. The stock has fluctuated within a day range of 5.700 to 6.130, while its 52-week range spans from 3.420 to 7.950.
What Is TriSalus Life Sciences (TLSI) Price Target According to Analysts?
The average 12-month price target for TriSalus Life Sciences is USD11.5, with a high estimate of USD16 and a low estimate of USD9. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +98.96% Upside potential.
What Is the TLSI After Hours Price?
TLSI's last after hours stock price is 5.990, the stock has decreased by -0.120, or -1.960%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.